VAERS Explorer
Back to explore

Report #2895704

Received May 7, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Apr 14, 2026
Onset
Apr 24, 2026
Days to onset
10
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (1)

Pustule

Symptom narrative

Pustules; This non-serious case was reported by a consumer and described the occurrence of pustule in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (had multiple times) and chickenpox. Concurrent medical conditions included celiac disease. On 14-APR-2026, the patient received the 1st dose of Shingrix. On 24-APR-2026, 10 days after receiving Shingrix, the patient experienced pustule (Verbatim: Pustules). The outcome of the pustule was not resolved. It was unknown if the reporter considered the pustule to be related to Shingrix. It was unknown if the company considered the pustule to be related to Shingrix. Additional Information: GSK Receipt Date: 27-APR-2026 The symptoms was not treated. The batch number was not provided and a request for this information has been made.

Current illness

Celiac disease

Medical history

Medical History/Concurrent Conditions: Chickenpox; Shingles (had multiple times)